CAS 109844-92-0 appears in our catalog under these names: LCS3/ 99.68% (existing batch purity), LCS3, N-(4-chlorophenyl)-5-nitro-2-furancarboxamide, LCS3, 99.43%. Offered by: TargetMol, GLPBio, Chemat, MedChemExpress. Available pack sizes: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 500mg, 10 mg.
LCS3 is a reversible and uncompetitive glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) inhibitor (IC50=3.3 uM and 3.8 uM, respectively). LCS3 shows anti-tumor activity, and induces apoptosis. LCS3 can be used in lung adenocarcinoma (LUAD) research.
Source: ChEBI
| Molecular formula | C11H7ClN2O4 |
|---|---|
| Molecular weight | 266.64 g/mol |
| IUPAC name | N-(4-chlorophenyl)-5-nitrofuran-2-carboxamide |
| InChIKey | JDBZJNUHQINERI-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC=C1NC(=O)C2=CC=C(O2)[N+](=O)[O-])Cl |
Computed by PubChem (NCBI)